---
figid: PMC11854110__12943_2025_2254_Fig2_HTML
figtitle: Action of circRNAs participated in the chemotherapy resistance of cancer
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC11854110
filename: 12943_2025_2254_Fig2_HTML.jpg
figlink: /pmc/articles/PMC11854110/figure/F2/
number: F2
caption: Mechanisms of action of circRNAs participated in the chemotherapy resistance
  of cancer. Several circRNAs are involved in cancer chemotherapy resistance by influencing
  the gene alterations of cellular metabolism, epithelial-mesenchymal transition,
  apoptosis, autophagy, and exosome through regulating expression of potential target
  genes and related signalling pathway
papertitle: Role of circular RNAs in cancer therapy resistance
reftext: Wenjuan Liu, et al. Mol Cancer. 2025;24(NA).
year: '2025'
doi: 10.1186/s12943-025-02254-5
journal_title: Molecular Cancer
journal_nlm_ta: Mol Cancer
publisher_name: BMC
keywords: Circular RNAs | Exosome | Tumour immunity | Drug resistance | Radioresistance
automl_pathway: 0.9316306
figid_alias: PMC11854110__F2
figtype: Figure
redirect_from: /figures/PMC11854110__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC11854110__12943_2025_2254_Fig2_HTML.html
  '@type': Dataset
  description: Mechanisms of action of circRNAs participated in the chemotherapy resistance
    of cancer. Several circRNAs are involved in cancer chemotherapy resistance by
    influencing the gene alterations of cellular metabolism, epithelial-mesenchymal
    transition, apoptosis, autophagy, and exosome through regulating expression of
    potential target genes and related signalling pathway
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - YBX1
  - TGFB1
  - PRKAA2
  - SMAD2
  - SMAD3
  - MIR660
  - STAT3
  - STK11
  - WNT2B
  - IL6R
  - MIR429
  - BECN1
  - AKT1
  - AKT2
  - AKT3
  - EPHB2
  - MAPK1
  - MAPK3
  - RAF1
  - RNASE3
  - BCL2
  - HIPK3
  - CTNNB1
  - MIR637
  - SMAD4
  - PRPF19
  - WNT1
  - WNT2
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - Sorafenib
  - Nucleus
  - Cancer
  - cancer
---
